Publication Ethics and Malpractice Statement

Current Pharmaceutical Research (CPR) is committed to maintaining the highest standards of publication ethics and academic integrity and follows relevant principles, guidance, and best practices established by the Committee on Publication Ethics (COPE) and other recognized international publishing-ethics organizations. 

Current Pharmaceutical Research (CPR) is not currently a formal member of COPE, but it fully adheres to and follows COPE's Code of Conduct and Best Practice Guidelines for Journal Editors in all publishing ethics and misconduct procedures.

Authorship and Contributorship Policy

Authorship should be limited to individuals who have made significant intellectual contributions to the conception, design, execution, or interpretation of the reported research. All authors must have contributed sufficiently to the work, approved the final version of the manuscript, agreed to its submission for publication, and accept responsibility for the integrity and accuracy of the work. Contributions should be transparently described using appropriate CRediT (Contributor Roles Taxonomy) roles, where applicable. Individuals whose contributions do not meet the criteria for authorship should be appropriately acknowledged. Acquisition of funding, general supervision, administrative support, or language editing alone does not qualify an individual for authorship. Ghost, guest, and gift authorship are not permitted. The corresponding author is responsible for ensuring that all appropriate contributors are included in the author list and that all listed authors have approved the final manuscript and agreed to its submission.

Complaints and Appeals Policy

Authors, reviewers, and readers may submit complaints or appeals concerning editorial decisions, peer-review processes, publication delays, or suspected ethical misconduct by contacting the Editor-in-Chief at editor@CPR.org.in. All complaints and appeals are handled confidentially, fairly, and impartially, and are assessed in accordance with applicable editorial policies and relevant COPE guidance. Where appropriate, the journal may request supporting information or documentation from the parties involved. Appeals against editorial decisions must provide clear and substantive grounds for reconsideration. Complaints will not affect the impartial consideration of current or future submissions, and appropriate corrective action will be taken where an investigation establishes an error or ethical concern.

Conflict of Interest and Competing Interests Policy

Authors must disclose any financial, personal, professional, or other relationships or circumstances that could reasonably be perceived as influencing or potentially biasing the research, interpretation of results, or publication process. All sources of financial support and relevant competing interests should be declared at the time of manuscript submission. Editors and reviewers must disclose any actual, potential, or perceived conflict of interest and should decline to handle or review a manuscript when such a conflict could compromise their objectivity or independence. The journal’s editorial decisions are based solely on the scientific quality, originality, validity, and relevance of the manuscript and are not influenced by financial or other competing interests. Where necessary, the journal may request additional disclosures or take appropriate measures to manage identified conflicts.

Data Sharing and Data Availability Policy

Authors are encouraged to make the data supporting the findings of their research available through appropriate and recognized data repositories whenever possible. A clear Data Availability Statement should be included in the manuscript, indicating where the supporting data can be accessed or explaining why the data are not publicly available. Where data cannot be shared because of privacy, ethical, legal, confidentiality, or other legitimate restrictions, authors should provide an appropriate statement describing the reason for restricted access. Authors remain responsible for ensuring that shared data comply with applicable ethical, legal, institutional, and confidentiality requirements. Where applicable, authors should provide relevant dataset identifiers, repository information, or access conditions to facilitate verification and reproducibility of the reported findings.

Ethical Oversight (Human & Animal Rights)

Research involving human participants, human-derived materials, identifiable personal or medical data, or animals must be conducted in accordance with applicable international ethical standards, relevant national and institutional regulations, and recognized guidelines, including the Declaration of Helsinki where applicable. Manuscripts reporting such research must include a clear statement identifying the approving Institutional Review Board (IRB), Ethics Committee, or relevant regulatory authority, together with the approval or reference number where applicable. For research involving human participants, appropriate informed consent must be obtained and documented, including consent for publication where required. If a study is exempt from ethical approval, authors must provide the basis for the exemption and identify the authority or committee granting or confirming the exemption. Animal research must comply with applicable institutional and national standards for the care and use of laboratory animals, and the manuscript should provide details of the relevant ethical approval. The journal reserves the right to request supporting ethical approval documentation where necessary.

Post-Publication Discussions

CPR supports constructive post-publication discussion and scholarly debate concerning articles published in the journal. Readers may submit Letters to the Editor, commentaries, or other substantive communications that address the methodology, interpretation, findings, or scientific significance of a published article. All such submissions are subject to appropriate editorial assessment and, where applicable, peer review. Authors of the original article will be given a reasonable opportunity to respond to substantive comments or criticisms before a response is published. Post-publication discussions must remain evidence-based, respectful, and free from personal or defamatory statements. Where a post-publication discussion identifies a potential error or ethical concern, the journal may initiate an appropriate editorial assessment and take corrective action in accordance with relevant publication-ethics guidelines.